about
Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma.Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitisOutcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer.Immunosuppression for ipilimumab-related toxicity can cause pneumocystis pneumonia but spare antitumor immune control.Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.Infliximab for IPILIMUMAB-Related Colitis--LetterSalvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell CancerSuccessful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritisPaclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
P50
Q37012639-F9459474-2C3F-4A3C-9697-2AED44647503Q37308199-33524D1A-E53D-4C28-805E-791977AEC729Q37338005-04E3AD3C-B545-4787-A496-79B28678CA1AQ37688103-2737F85C-8D25-4E11-A3F5-EBE4567F1F9BQ39148814-DC2BF92E-7FC3-442B-B7D7-E01C2D7CEEF1Q40545094-4BA23022-3BF7-44C1-82E6-F91BE631923BQ40959994-3BD2F5C5-C2BD-4391-9101-869E1672BA66Q47239043-6A86D6C4-3CF1-4555-9323-3542A017620AQ58025377-6AF2B919-28EA-4313-A160-8EAB70FE1CF5Q90986521-2041353A-47C4-46EF-AAE1-5F4D58A8D745Q92737089-B1FB14C0-0C5D-4CC1-B147-3A604E97CAB7Q93072854-67C747AE-D1DA-4FC4-82CD-55AEF1421B71
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Matthew Wheater
@en
Matthew Wheater
@nl
type
label
Matthew Wheater
@en
Matthew Wheater
@nl
prefLabel
Matthew Wheater
@en
Matthew Wheater
@nl
P31
P496
0000-0001-6561-5290